Trial Profile
Phase II study of biweekly cetuximab and irinotecan for unresectable advanced/recurrent colorectal cancer. Phoenix study
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Cetuximab
- Indications Colorectal cancer
- Focus Therapeutic Use
- 18 May 2016 New trial record